Biologic drug reduces symptoms and hospitalizations in severe pulmonary hypertension – BioNews Central Adding the biologic drug sotatercept to standard therapy within the first year after diagnosis significantly lowers the risk of disease worsening in patients with the most severe form of pulmonary hypertension. ...

Adding the #BiologicDrug #sotatercept to standard therapy within the first year after diagnosis significantly lowers the risk of disease worsening in patients with the most severe form of #PulmonaryHypertension.
#PulmonaryArterialHypertension